Metabotropic glutamate receptor: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 29: | Line 29: | ||
{{GPCR-stub}} | {{GPCR-stub}} | ||
{{Neuroscience-stub}} | {{Neuroscience-stub}} | ||
== Metabotropic_glutamate_receptor == | |||
<gallery> | |||
File:7epa_mGluR2_homodimer_inactive.png|Inactive mGluR2 homodimer structure | |||
File:L-Glutaminsäure_-_L-Glutamic_acid.svg|L-Glutamic acid structure | |||
File:Quisqualic_acid.svg|Quisqualic acid structure | |||
</gallery> | |||
Latest revision as of 04:05, 18 February 2025
Metabotropic glutamate receptors (mGluRs) are a type of glutamate receptor that are active through an indirect metabotropic process. They are members of the group C family of G-protein-coupled receptors, or GPCRs. These receptors are found in the neurons of both the central nervous system and the peripheral nervous system.
Function[edit]
Metabotropic glutamate receptors are involved in a variety of physiological processes. They are responsible for modulating neuronal excitability, acting as a switch for different forms of synaptic plasticity, and regulating the production of new neurons in the adult brain (neurogenesis). They also play a role in the modulation of sensory information, including olfactory, taste, and visual information.
Classification[edit]
Metabotropic glutamate receptors are classified into three groups (Group I, II, and III) based on their G protein coupling, pharmacological profile, and distribution in the brain.
- Group I includes mGluR1 and mGluR5 and is primarily coupled to Gq/11, which activates Phospholipase C and causes the release of Inositol trisphosphate and Diacylglycerol.
- Group II includes mGluR2 and mGluR3 and is primarily coupled to Gi/o, which inhibits Adenylyl cyclase and decreases the production of cAMP.
- Group III includes mGluR4, mGluR6, mGluR7, and mGluR8 and is also primarily coupled to Gi/o.
Clinical significance[edit]
Metabotropic glutamate receptors are potential targets for the treatment of various neurological disorders, including schizophrenia, Parkinson's disease, Fragile X syndrome, and anxiety disorders. Drugs that act on these receptors may also be useful in the treatment of neurodegenerative diseases and mood disorders.
See also[edit]
This GPCR-related article is a stub. You can help WikiMD by expanding it.

This article is a neuroscience stub. You can help WikiMD by expanding it!
Metabotropic_glutamate_receptor[edit]
-
Inactive mGluR2 homodimer structure
-
L-Glutamic acid structure
-
Quisqualic acid structure